Rosiglitazone controversy continues to smolder Ask the Experts: DPP-4 inhibitors in the management of type 2 diabetesQ. What is the recommended role of DPP-4 inhibitors, such as sitagliptin and saxagliptin, in the management of type 2 diabetes? Low-dose combo therapy fends off diabetes Canadian trial of rosiglitazone-metformin pill not powered for adverse cardiovascular events Canadian researchers disagree on halting rosiglitazone trial Canadian researchers disagree on halting trial of diabetes drug rosiglitazone Expand diabetes surgery, experts urge Bariatric procedures should be offered to type 2 patients even if not morbidly obese, conference hears Health and Disease Management: Diabetes Connecting with patients can make all the difference Health and Disease Management: Diabetes & Nutrition What’s on the menu for diabetes patients? Health and Disease Management: Blood glucose management Diabetes Care in Action program celebrates 10th anniversary Victoza: first GLP-1 analogue for type 2 diabetes First Previous 60 61 62 63 64 Next Last
